HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
expression	B:C1171362
and	O
high	O
microvessel	O
density	O
are	O
characteristic	O
features	O
in	O
serrated	B:C3272809
colorectal	I:C3272809
cancer	I:C3272809
.	O

Serrated	B:C3272809
colorectal	I:C3272809
adenocarcinoma	I:C3272809
(	O
Serrated	B:C3272809
colorectal	I:C3272809
adenocarcinoma	I:C3272809
)	O
is	O
a	O
morphologically	B:C0543482
distinct	O
subtype	B:C0449560
of	O
colorectal	B:C1527249
cancer	I:C1527249
(	O
colorectal	B:C1527249
cancer	I:C1527249
)	O
,	O
in	O
which	O
increased	O
HIF	B:C1333897
-	I:C1333897
1α	I:C1333897
mRNA	B:C1515670
expression	I:C1515670
and	O
HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
protein	I:C1528322
stabilization	B:C1327386
are	O
typical	O
features	O
.	O

Here	O
we	O
aimed	O
to	O
further	O
elucidate	O
HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
protein	B:C1171362
expression	I:C1171362
in	O
serrated	B:C3272809
and	O
non-serrated	B:C0009402
colorectal	I:C0009402
carcinomas	I:C0009402
(	O
carcinomas	B:C0009402
)	O
and	O
their	O
precursor	B:C0221198
lesions	I:C0221198
and	O
its	O
association	O
with	O
vascular	B:C1256770
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
(	O
vascular	B:C1256770
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
)	O
and	O
microvascular	O
density	O
(	O
MVD	O
)	O
.	O

HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
and	O
vascular	B:C1256770
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
expressions	B:C1171362
were	O
determined	O
immunohistochemically	O
in	O
134	O
serrated	B:C3266123
polyps	I:C3266123
(	O
serrated	B:C3266123
polyps	I:C3266123
)	O
,	O
104	O
non-serrated	B:C0001430
adenomas	I:C0001430
(	O
non-serrated	B:C0001430
adenomas	I:C0001430
)	O
,	O
81	O
SACs	B:C3272809
,	O
and	O
74	O
matched	O
conventional	B:C0007112
adenocarcinomas	I:C0007112
(	O
conventional	B:C0007112
adenocarcinomas	I:C0007112
)	O
and	O
were	O
correlated	O
with	O
morphology	O
,	O
clinicopathological	B:C0030667
features	I:C0030667
,	O
and	O
MVD	O
.	O

In	O
premalignant	B:C0850639
lesions	I:C0850639
,	O
both	O
HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
and	O
vascular	B:C1256770
endothelial	I:C1256770
growth	I:C1256770
factor	I:C1256770
were	O
expressed	B:C1171362
in	O
the	O
vast	O
majority	O
of	O
serrated	B:C3266123
polyps	I:C3266123
and	O
non-serrated	B:C0001430
adenomas	I:C0001430
.	O

In	O
carcinomas	B:C1527249
,	O
HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
protein	I:C1528322
was	O
also	O
present	O
in	O
77.8	O
%	O
of	O
SACs	B:C3272809
,	O
while	O
only	O
20.3	O
%	O
of	O
conventional	B:C0007112
adenocarcinomas	I:C0007112
were	O
HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
proficient	O
.	O

MVD	O
was	O
significantly	O
higher	O
in	O
SACs	B:C3272809
,	O
but	O
the	O
serrated	B:C3266123
morphology	O
was	O
the	O
only	O
significant	O
predictor	O
of	O
MVD	O
in	O
colorectal	B:C1527249
cancer	I:C1527249
in	O
multivariate	O
analyses	O
.	O

HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
protein	I:C1528322
is	O
often	O
stabilized	B:C1293130
in	O
well	O
-	O
vascularized	O
SACs	B:C3272809
,	O
suggesting	O
hypoxia	B:C0242184
-	O
independent	B:C1293130
stabilization	I:C1293130
of	O
HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
.	O

Moreover	O
,	O
HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
stabilization	B:C1327386
did	O
not	O
associate	O
with	O
oncogenic	B:C0007090
activation	B:C0017255
of	O
BRAF	B:C0812241
or	O
KRAS	B:C1537502
or	O
Von	B:C0694897
Hippel	I:C0694897
-	I:C0694897
Lindau	I:C0694897
(	O
Von	B:C0694897
Hippel	I:C0694897
-	I:C0694897
Lindau	I:C0694897
)	O
mutation	B:C0596611
.	O

Prevalent	O
HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
expression	B:C1171362
in	O
Serrated	B:C3272809
colorectal	I:C3272809
adenocarcinoma	I:C3272809
and	O
its	O
precursors	O
support	O
the	O
importance	O
of	O
HIF	B:C1528322
-	I:C1528322
1α	I:C1528322
-	O
mediated	O
pathways	B:C1704259
for	O
the	O
serrated	B:C3272809
route	I:C3272809
of	I:C3272809
colorectal	I:C3272809
carcinogenesis	I:C3272809
.	O

